NYSE · Healthcare
Booz Allen Hamilton Holding Corp (BAH)
As-reported financials and recent SEC filings for Booz Allen Hamilton Holding Corp, latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$11.22B
Net income
$851.0M
Net margin
7.6%
Diluted EPS
$6.90
ROE
77.0%
P/E (TTM)
9.0×
Market cap
$7.46B
Debt / equity
3.5×
Income statement (as reported)
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $11.22B | $11.98B | $10.66B | $9.26B | $8.36B |
| Gross profit | $5.91B | $6.56B | $5.74B | $4.95B | $4.46B |
| Operating income | $1.03B | $1.37B | $1.01B | $447.0M | $685.2M |
| Net income | $851.0M | $935.0M | $606.0M | $272.0M | $466.7M |
| Diluted EPS | $6.90 | $7.25 | $4.59 | $2.03 | $3.44 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-22
View on EDGAR →DEFA14A2026-06-11
View on EDGAR →DEF 14A2026-06-11
View on EDGAR →32026-06-04
View on EDGAR →1442026-06-04
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →42026-05-28
View on EDGAR →Go deeper on BAH
Search Booz Allen Hamilton Holding Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.